2023 Annual Meeting | C99 - The Global Burden of Neurologic Diseases

Date Monday 04/24/23

Time 01:00 PM - 03:00 PM EST Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Mehari Gebreyohanns, MD, FAAN

Topic(s) Global Health and Neuroepidemiology

Learning Objectives Participants should be familiar with the global burden of stroke and dementia, two neurologic conditions with major global burden for disability and mortality; the disparity that exists in terms of lack of culturally appropriate tools for awareness and assessment; resources for acute treatment and rehabilitation services and outcomes across the globe; and the initiatives that are taking place to close the gap between high-income countries and low- and middle-income countries (LMICs), including in countries in the Sub-Saharan Africa region where the needs are acute.

CME Available 2.00 CME credits

Core Competencies Systems-based Practice

Program Level Intermediate

Program Tracks Diversity, Equity, and Inclusion

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Didactic

Event Timeline
01:00 PM - 01:35 PM EST	Speaker	Global Burden of Stroke: Epidemiology, Challenges, and Opportunities Morgan Prust, MD
01:35 PM - 02:10 PM EST	Speaker	Global Burden of Dementia Monica M. Diaz, MD
02:10 PM - 02:45 PM EST	Speaker	Implementation of Culturally Adapted Tools for Stroke Awareness and Care: Case of Ethiopia Mehari Gebreyohanns, MD, FAAN
02:45 PM - 03:00 PM EST	Discussion	Questions and Answers Mehari Gebreyohanns, MD, FAAN, Monica M. Diaz, MD, Morgan Prust, MD

Faculty Disclosures
Mehari Gebreyohanns, MD, FAAN	Dr. Gebreyohanns has nothing to disclose.
Monica M. Diaz, MD	The institution of Dr. Diaz has received research support from Alzheimer's Association. The institution of Dr. Diaz has received research support from American Academy of Neurology. The institution of Dr. Diaz has received research support from Merck. The institution of Dr. Diaz has received research support from CorEvitas. The institution of Dr. Diaz has received research support from Celgene Corporation/Bristol-Myers Squibb. The institution of Dr. Diaz has received research support from Novartis. The institution of Dr. Diaz has received research support from Bodford Family Transverse Myelitis Center Fund.
Morgan Prust, MD	Dr. Prust has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Edelman & Edelman, PC.